Cite
HARVARD Citation
Saunders, M. et al. (n.d.). 666TiPA phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL). Annals of oncology. p. . [Online].